{"id":9481,"date":"2024-08-09T18:50:37","date_gmt":"2024-08-09T10:50:37","guid":{"rendered":"https:\/\/www.excelsiormedical.com.tw\/?p=9481"},"modified":"2024-09-02T16:23:12","modified_gmt":"2024-09-02T08:23:12","slug":"announcement-of-the-decision-by-the-board-of-directors-for-the-ex-rights-record-date-of-stock-dividends-2","status":"publish","type":"post","link":"https:\/\/www.excelsiormedical.com.tw\/en\/investors\/announcement-of-the-decision-by-the-board-of-directors-for-the-ex-rights-record-date-of-stock-dividends-2\/","title":{"rendered":"Announcement of the decision by the Board of Directors for the ex-rights record date of stock dividends."},"content":{"rendered":"

 <\/p>\n\n\n\n\n\n\n
SEQ_NO<\/td>\n\u00a01<\/td>\nDate of announcement<\/td>\n2024\/08\/09<\/td>\nTime of announcement<\/td>\n18:50:13<\/td>\n<\/tr>\n
Subject<\/td>\n\n
Announcement of the decision by the Board of Directors\r\nfor the ex-rights record date of stock dividends.<\/pre>\n<\/td>\n<\/tr>\n
Date of events<\/td>\n2024\/08\/09<\/td>\nTo which item it meets<\/td>\nparagraph 14<\/td>\n<\/tr>\n
Statement<\/td>\n\n
1.Date of the resolution by the board of directors or \r\n  shareholders meeting or decision by the Company:\r\n  2024\/08\/09\r\n2.Type of ex-rights or ex-dividend (please enter: \r\n  \u201cEx-rights\u201d,\u201dEx-dividend\u201d, or \u201dEx-rights and \r\n   dividend\u201d):Ex-rights\r\n3.Type and monetary amount of common stock dividend \r\n  distribution:Stock dividends NT$0.5 per share of common\r\n  stock,(50 shares allotted gratuitously for every \r\n  thousand shares).\r\n4.Ex-rights (ex-dividend) trading date:2024\/08\/26\r\n5.Last date before book closure:2024\/08\/27\r\n6.Book closure starting date:2024\/08\/28\r\n7.Book closure ending date:2024\/09\/01\r\n8.Ex-rights (ex-dividend) record date:2024\/09\/01\r\n9.Deadline for applying the conversion of the bond:\r\n  Not Applicable.\r\n10.The closure period for the conversion of the bond will\r\n   start from the date:Not Applicable.\r\n11.The closure period for the conversion of the bond will\r\n   end on the date:Not Applicable.\r\n12.Payment date of common stock cash dividend \r\n   distribution: Not Applicable.\r\n13.Any other matters that need to be specified:\r\n   1.The matters related to this new common share \r\n     issuance through the increase of capital by \r\n     earnings recapitalization, please refer to the \r\n     Company's public disclosure and filing of the record\r\n     date fixed by the Company for distribution of \r\n     dividends, bonuses or other benefits.\r\n   2.This dividend distribution notice is also being \r\n     handled through \u201ceNotice Platform\u201d by the Taiwan \r\n     Depository & Clearing Corporation (TDCC).\r\n     Shareholders are kindly requested to log into the\r\n     website: https:\/\/stockservices.tdcc.com.tw and \r\n     register their consent to receive electronic \r\n     notifications of dividend distribution via the \r\n     eNotice Platfrom one business day prior to the \r\n     Ex-right\/ Ex-dividend book closure date(i.e.,\r\n     before Aug 26, 2024). By doing so,\r\n     shareholders can receive the dividend distribution \r\n     notice via email.(For those who provide their \r\n     consent after Aug 27, 2024,the electronic \r\n     notification will apply to the next dividend \r\n     distribution.)<\/pre>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n","protected":false},"excerpt":{"rendered":"
  SEQ_NO \u00a01 Date of announcement 2024\/08\/09 Time of announcement 18:50:13 Subject Announcement of the decision by the Board of Directors for the ex-rights record date of stock dividends. Date of events 2024\/08\/09 To which item it meets paragraph 14 Statement 1.Date of the resolution by the board of directors or shareholders meeting or decision …<\/p>\n
  Announcement of the decision by the Board of Directors for the ex-rights record date of stock dividends.<\/span> Read More »<\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"default","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[72,102],"tags":[],"class_list":["post-9481","post","type-post","status-publish","format-standard","hentry","category-investors","category-material-information"],"_links":{"self":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9481","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/comments?post=9481"}],"version-history":[{"count":5,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9481\/revisions"}],"predecessor-version":[{"id":9486,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/posts\/9481\/revisions\/9486"}],"wp:attachment":[{"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/media?parent=9481"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/categories?post=9481"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.excelsiormedical.com.tw\/en\/wp-json\/wp\/v2\/tags?post=9481"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}